Standardization of Cystatin C: development of primary and secondary reference preparations.
(2008) In Scandinavian Journal of Clinical & Laboratory Investigation 68(s241). p.67-70- Abstract
- A Primary Reference Preparation has been produced using pure, recombinant, Cystatin C in a solvent of 0.1 mol/L KCl. Dry mass determination of the Primary Reference Preparation resulted in a Cystatin C concentration of 5.20 g/L. Agarose-electrophoresis and SDS-electrophoresis, as well as N-terminal sequencing, verified the purity, homogeneity and identity of Cystatin C in the Primary Reference Preparation. For the Secondary Reference Preparation, a serum pool was collected and stabilized. A pilot batch was made to verify the selected procedure and spiking with the pure, recombinant Cystatin C. The final Secondary Reference Preparation is now produced (4468 vials) and ready for value assignment and further characterization.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1223070
- author
- Blirup, Soren LU ; Grubb, Anders LU ; Lindström, Veronica LU ; Schmidt, C and Althaus, H
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Primary Reference Preparation, Secondary Reference Preparation, standardization of Cystatin C, dry mass determination, Cystatin C
- in
- Scandinavian Journal of Clinical & Laboratory Investigation
- volume
- 68
- issue
- s241
- pages
- 67 - 70
- publisher
- Informa Healthcare
- external identifiers
-
- wos:000256682700012
- pmid:18569968
- scopus:45849097552
- ISSN
- 1502-7686
- DOI
- 10.1080/00365510802150067
- language
- English
- LU publication?
- yes
- id
- e5973629-86fa-4955-bf67-5d6a17d8f23a (old id 1223070)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/18569968?dopt=Abstract
- date added to LUP
- 2016-04-01 12:51:08
- date last changed
- 2023-01-11 07:07:04
@article{e5973629-86fa-4955-bf67-5d6a17d8f23a, abstract = {{A Primary Reference Preparation has been produced using pure, recombinant, Cystatin C in a solvent of 0.1 mol/L KCl. Dry mass determination of the Primary Reference Preparation resulted in a Cystatin C concentration of 5.20 g/L. Agarose-electrophoresis and SDS-electrophoresis, as well as N-terminal sequencing, verified the purity, homogeneity and identity of Cystatin C in the Primary Reference Preparation. For the Secondary Reference Preparation, a serum pool was collected and stabilized. A pilot batch was made to verify the selected procedure and spiking with the pure, recombinant Cystatin C. The final Secondary Reference Preparation is now produced (4468 vials) and ready for value assignment and further characterization.}}, author = {{Blirup, Soren and Grubb, Anders and Lindström, Veronica and Schmidt, C and Althaus, H}}, issn = {{1502-7686}}, keywords = {{Primary Reference Preparation; Secondary Reference Preparation; standardization of Cystatin C; dry mass determination; Cystatin C}}, language = {{eng}}, number = {{s241}}, pages = {{67--70}}, publisher = {{Informa Healthcare}}, series = {{Scandinavian Journal of Clinical & Laboratory Investigation}}, title = {{Standardization of Cystatin C: development of primary and secondary reference preparations.}}, url = {{http://dx.doi.org/10.1080/00365510802150067}}, doi = {{10.1080/00365510802150067}}, volume = {{68}}, year = {{2008}}, }